Status:
COMPLETED
A Research Study Looking at Specific Tissue of the Umbilical Cord
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
Children's Mercy Hospital Kansas City
Conditions:
Varices of Umbilical Cord
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to isolate Umbilical cord Wharton's jelly matrix to be used as a scaffold for tissue regenerative applications, including avascular necrosis.
Detailed Description
Our working hypothesis is that umbilical cord blood Wharton's Jelly matrix has all the biochemical and biomechanical characteristics needed in an ideal scaffold for tissue engineering. Accordingly, we...
Eligibility Criteria
Inclusion
- Pregnant Women
- 18 years of age or older
- willing to donate umbilical cord units
Exclusion
- less than 18 years of age
- Has Hepatitis or HIV
- Considered High Risk
- Scheduled for C-Section due to complications during current pregnancy
- Delivered prior to Full Term
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01166776
Start Date
June 1 2010
End Date
July 1 2016
Last Update
August 22 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
2
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108